SCHEMBL23948926

SCHEMBL23948926

c1ccc(-n2c3ccc(-c4nc5ccccc5[nH]4)cc3c3c2ccc2c4ccccc4n(-c4ccccc4)c23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 2/20 0.44
▸ NPC1 O15118 9/20 0.43
▸ RAB9A P51151 9/20 0.43
▸ GAA P10253 1/20 0.43
▸ SMN1; SMN2 Q16637 10/20 0.41
▸ POLB P06746 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KDM4E B2RXH2 9/20 0.40
▸ ALDH1A1 P00352 8/20 0.40
▸ HPGD P15428 8/20 0.40
▸ MAPT P10636 5/20 0.40
▸ PKM P14618 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ HSD17B10 Q99714 4/20 0.40
▸ TP53 P04637 2/20 0.40
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21890530 0.95 NPC1 (0.42) NPY5RNPC1RAB9AGAASMN1; SMN2
SCHEMBL21890257 0.95 NPC1 (0.42) NPY5RNPC1RAB9AGAASMN1; SMN2
SCHEMBL21298554 0.89 NPY5R (0.53) NPY5RNPC1RAB9AGAASMN1; SMN2
SCHEMBL21890463 0.87 NPC1 (0.47) NPY5RNPC1RAB9AGAASMN1; SMN2
SCHEMBL21298160 0.86 NPC1 (0.51) NPY5RNPC1RAB9AGAASMN1; SMN2
SCHEMBL23948708 0.85 NPY5R (0.50) NPY5RNPC1RAB9AGAASMN1; SMN2
SCHEMBL24501022 0.84 NPC1 (0.50) NPY5RNPC1RAB9AGAASMN1; SMN2
SCHEMBL21890267 0.84 NPC1 (0.49) NPY5RNPC1RAB9AGAASMN1; SMN2
SCHEMBL21890438 0.83 NPC1 (0.48) NPY5RNPC1RAB9AGAASMN1; SMN2
SCHEMBL23132196 0.81 NPY5R (0.49) NPY5RNPC1RAB9AGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2021-10-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure TEAD4, TEAD2, TEAD1 NPY5R 4684/4885NPC1 4146/4885RAB9A 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback